We test all of these in our genetics report and walk through the interpretation in our pharmacogenomics guide
According to a 2023 consensus from the American Diabetes Association, agents with proven MACE benefit should be prioritized for patients with established atherosclerotic cardiovascular disease (ASCVD) or chronic kidney disease (CKD)
doi: 10.3390/ijms21218253 6 ZouHAliWDengKChenYSunJWangTet al
Semaglutide is administered as a once-weekly subcutaneous injection using a small, pre-filled pen injector similar to an insulin pen
Retatrutide helps control hunger and makes you feel full
This triple agonism creates synergistic effects across central and peripheral pathways, influencing appetite regulation, energy expenditure, glucose homeostasis, lipid metabolism, and substrate utilization